Corneal collagen crosslinking may manage superficial microbial keratitis

Article

A study published in The British Journal of Ophthalmology found that corneal collagen crosslinking appears to be an effective procedure in the management of superficial microbial keratitis.

A study published in The British Journal of Ophthalmology found that corneal collagen crosslinking appears to be an effective procedure in the management of superficial microbial keratitis.

The study looked at 15 eyes of 15 patients with microbial keratitis-nine with bacterial keratitis and six with fungal keratitis. The depth of the infiltrate was determined clinically with slit lamp and measured manually using anterior segment OCT. The patients were treated with antibiotics/antifungals, and those who did not respond to at least two weeks of topical medications underwent corneal collagen crosslinking, followed by the same preoperative topical medications. Follow-up appointments were scheduled every third day to observe signs of resolution of the microbial keratitis.

According to the study, six of the nine patients with bacterial keratitis and three of the six patients with fungal keratitis resolved after the corneal collagen crosslinking procedure. However, patients with deep stromal keratitis or endothelial plaque failed to resolve. All of the patients had resolution of pain on the first day post-op. 

Recent Videos
A. Philip Aitsebaomo, O.D., Ph.D. outlines his talk on treating patients with prosthetic eyes
Dr Clark Chang overviews how to fit wavefront guided contact lenses at Optometry's Meeting
Kurt Moody, OD, FAAO, describes how to fit multifocal contact lenses in a way that patients love
Christi Closson, OD, FAAO, details fitting contact lenses for astigmatism and other products by Johnson and Johnson
Susan Gromacki, OD, MS, FAAO, FSLS
Susan Gromacki, OD, MS, FAAO, FSLS
William Reindel, OD
Marjorie Rah, OD, PhD, FAAO
Amy Butler of Bausch + Lomb details the company's recycling programs and initiatives for contact lenses and other eye care products
© 2024 MJH Life Sciences

All rights reserved.